Clinical Trials · NCT06283641
Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 300
- Start date
- Apr 2024
- Locations
- 15 sites, Taiwan
- Primary endpoint
- Incidence of adverse events (AEs) by preferred term (PT)